ARAY

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Accuray Inc

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. The company invents unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases-while making commonly treatable cases even easier-to meet the full spectrum of patient needs. Accuray is dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as they partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide.
CEO
Joshua Levine
Employees
932
Headquarters

1310 Chesapeake Ter
Sunnyvale, California 94089
Phone: 14087164600
www.accuray.com

News

Investing in Accuray Incorporated (ARAY) might be an excellent idea, but the stock is currently overvalued/undervalued
Nov 04, 2022 14:24pm

Accuray Incorporated (NASDAQ:ARAY) closed Thursday at $2.03 per share, up from $1.93 a day earlier. While Accuray Incorporated has overperformed by 5.18%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ARAY fell by -63.22%, with highs and lows ranging from $5.93 to $1.70, whereas the simple […]


Source:US Post News
Accuray Results Weren''t Bad, But There''s Still No Growth
Nov 03, 2022 17:14pm

Accuray looks undervalued on discounted cash flow. Read why ARAY stock could well move before company reaches and holds $100M/quarter in orders.


Source:Seeking Alpha
Accuray Incorporated (ARAY) Q1 2023 Earnings Call Transcript
Nov 03, 2022 01:18am

Accuray Incorporated (NASDAQ:NASDAQ:ARAY) Q1 2023 Results Conference Call November 02, 2022 04:30 AM ET Company Participants Ken Mobeck - Vice President of Finance and Investor Relations…


Source:Seeking Alpha
Accuray Incorporated Q1 Loss increases, misses estimates
Nov 02, 2022 20:46pm

WASHINGTON (dpa-AFX) - Accuray Incorporated (ARAY) released Loss for its first quarter that increased from the same period last year and missed the Street estimates.The company''s bottom line total…


Source:Finanz Nachrichten
Accuray GAAP EPS of -$0.06 misses by $0.02, revenue of $96.49M misses by $3.45M
Nov 02, 2022 20:44pm

Accuray press release (NASDAQ:ARAY): Q1 GAAP EPS of -$0.06 misses by $0.02.Revenue of $96.49M (-10.2% Y/Y) misses by $3.45M.Gross orders of $69.8 million, were flat versus the prior fiscal…


Source:Seeking Alpha
Accuray Reports Fiscal 2023 First Quarter Financial Results
Nov 02, 2022 20:07pm

Strong customer demand. Navigating FX and Supply Chain Challenges. Company reiterates full year guidance. SUNNYVALE, Calif., Nov. 2, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2023 ended September 30, 2022….


Source:PR Newswire
Accuray stock rises on filing for China approval of radiation therapy system
Nov 01, 2022 13:01pm

Accuray (ARAY) said the registration dossier for Tomo C radiation therapy system for the Type B market was submitted to China''s National Medical Products Administration…


Source:Seeking Alpha
Accuray Announces Tomo® C Registration Submission to China''s National Medical Products Administration
Nov 01, 2022 11:35am

SUNNYVALE, Calif., Nov. 1, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo® C radiation therapy system for the Type B market has been submitted to the Chinese National Medical Products…


Source:PR Newswire
GE Healthcare and Accuray Collaborate to Expand Access, Advance the Practice of Precision Radiation Therapy
Oct 21, 2022 16:00pm

Collaboration places emphasis on personalized medicine; brings together key precision diagnostic and treatment delivery tools aimed at creating shorter, more comfortable and more effective treatments for patients CHICAGO and SUNNYVALE, Calif. , Oct. 21, 2022 /PRNewswire/ -- GE Healthcare and


Source:Investors Accuray
Accuray launches CyberKnife platform in Africa for cancer patients (NASDAQ:ARAY)
Sep 30, 2022 13:24pm

Accuray (ARAY) said it had launched its CyberKnife platform in Africa for more patients to receive treatments with stereotactic radiosurgery ((SRS)) and stereotactic body radiation…


Source:Seeking Alpha
Accuray Announces First CyberKnife® Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients
Sep 30, 2022 11:30am

World''s Only Robotic Radiation Therapy Device Delivers Extremely Precise Treatments in Just 1 to 5 Out- Patient Sessions SUNNYVALE, Calif. , Sept. 30, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding its global footprint with the introduction of its


Source:Investors Accuray